oscar health inc - OSCR
OSCR
Close Chg Chg %
16.55 -0.42 -2.56%
Open Market
16.13
-0.42 (2.56%)
Volume: 4.37M
Last Updated:
Jan 20, 2026, 3:06 PM EDT
Company Overview: oscar health inc - OSCR
OSCR Key Data
| Open $15.98 | Day Range 15.82 - 16.35 |
| 52 Week Range 11.20 - 23.75 | Market Cap $4.38B |
| Shares Outstanding 264.68M | Public Float 210.80M |
| Beta 1.90 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$0.95 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 8.04M |
OSCR Performance
| 1 Week | 0.00% | ||
| 1 Month | 11.07% | ||
| 3 Months | -14.20% | ||
| 1 Year | 4.09% | ||
| 5 Years | N/A |
OSCR Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
12
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | HOLD | Average Target Price | 15.545 | |
| Number of Ratings | 12 | Current Quarters Estimate | 0.652 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | -0.051 | |
| Last Quarter’s Earnings | -0.88 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -1.271 | Next Fiscal Year Estimate | 0.987 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 8 | 8 | 11 | 10 |
| Mean Estimate | 0.65 | -0.02 | -0.05 | 0.99 |
| High Estimates | 1.19 | 0.16 | 0.44 | 1.55 |
| Low Estimate | 0.36 | -0.33 | -0.94 | 0.56 |
| Coefficient of Variance | 43.52 | -787.03 | -787.22 | 37.80 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 2 | 2 | 1 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 7 | 4 | 4 |
| UNDERWEIGHT | 1 | 1 | 1 |
| SELL | 2 | 4 | 4 |
| MEAN | Hold | Hold | Underweight |
SEC Filings for Oscar Health Inc - OSCR
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Oscar Health Inc - OSCR
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Apr 15, 2025 | Jeffery H. Boyd Director | 57,207 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 15, 2025 | David Plouffe Director | 1,734 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 15, 2025 | William J. Gassen Director | 1,530 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 8, 2025 | Mark T. Bertolini Chief Executive Officer; Director | 2,866,666 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Mark T. Bertolini Chief Executive Officer; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 27, 2025 | Janet Liang President, Oscar Insurance | 97,402 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Janet Liang President, Oscar Insurance | 147,637 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Adam McAnaney Chief Legal Officer | 123,376 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 27, 2025 | Adam McAnaney Chief Legal Officer | 185,004 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |